Utility of ^99mTc-Sestamibi Heart/Liver Uptake Ratio in Screening Nonalcoholic Fatty Liver Disease During Myocardial Perfusion Imaging.

Autor: Norouzi, Ghazal, Nikdel, Sara, Pirayesh, Elahe, Salimi, Yazdan, Amoui, Mahasti, Haghighatkhah, Hamidreza, Ghodsi Rad, Mohammad Ali, Javanijouni, Elmira, Khoshbakht, Sepideh

Publikováno v: Cancer Biotherapy & Radiopharmaceuticals; Dec2023, Vol. 38 Issue 10, p663-669, 7p

Utility of ^99m Tc-Sestamibi Heart/Liver Uptake Ratio in Screening Nonalcoholic Fatty Liver Disease During Myocardial Perfusion Imaging.

Autor: Norouzi G; Department of Nuclear Medicine, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Clinical Research Development Unit, Shohada-e Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Nikdel S; Department of Nuclear Medicine, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Pirayesh E; Department of Nuclear Medicine, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Clinical Research Development Unit, Shohada-e Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Salimi Y; Biomedical Engineering and Medical Physics Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Amoui M; Department of Nuclear Medicine, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Clinical Research Development Unit, Shohada-e Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Haghighatkhah H; Clinical Research Development Unit, Shohada-e Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Diagnostic Imaging, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Ghodsi Rad MA; Department of Nuclear Medicine, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Clinical Research Development Unit, Shohada-e Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Javanijouni E; School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Khoshbakht S; Department of Nuclear Medicine, Shohada-e Tajrish Medical Center, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Clinical Research Development Unit, Shohada-e Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Publikováno v: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2023 Dec; Vol. 38 (10), pp. 663-669. Date of Electronic Publication: 2022 Dec 20.